US Fertility Clinics Market to Increase at 2.6% CAGR through 2022, Predicts BCC Research in Its New Report Recently Added at MarketPublishers.com
10 Jan 2018 • by Natalie Aster
LONDON – By the end of 2017, the fertility clinics market in the US reached the value of appr. USD 3.6 billion. Through to 2022, this market is anticipated to continue increasing at a healthy 2.6% CAGR to amount to around USD 4.5 billion by the end of the projected period.
The country’s fertility drugs sector is set to rise from the value of USD 0.6 billion in 2017 to reach USD 0.8 billion in 2022, expanding at a 5.9% CAGR in the years ahead.
As of the year 2016, the dominant share (nearly 70%) of the total US fertility clinics market belonged to the assisted reproductive technology services, the value of this sector was estimated at appr. USD 2.4 billion.
The new research report “US Fertility Clinics Market” prepared by BCC Research gives access to a detailed guide to the US fertility clinics market landscape. It presents reliable, updated statistics; includes a detailed analysis of the main market segments with vital details on their shares and growth rates; identifies the unmet needs, touches upon the major aspects (like cases of infertility and major stages of fertility treatment) and discusses the hottest issues. The report provides the regional breakdown of fertility clinics in the US, highlight the existing services and technologies, gives info on the costs and price fluctuations. Besides, this report touches upon the historical development of the fertility clinics market in the US, describes the current market scenario and also evaluates the future growth prospects and threats. Moreover, this publication comprises a snapshot of the recent fertility industry developments in the country, covers the regulative framework, examines the competitive scenario and include brief profiles of the top players engaged in this industry.
For a full list of the publisher’s market research studies visit the BCC online page at MarketPublishers.com.